MDT

86.5

-0.05%↓

113.77

-1.1%↓

VEEV

171.16

-1.2%↓

HQY

81.09

-3.2%↓

PHR.US

9.11

+2.36%↑

MDT

86.5

-0.05%↓

113.77

-1.1%↓

VEEV

171.16

-1.2%↓

HQY

81.09

-3.2%↓

PHR.US

9.11

+2.36%↑

MDT

86.5

-0.05%↓

113.77

-1.1%↓

VEEV

171.16

-1.2%↓

HQY

81.09

-3.2%↓

PHR.US

9.11

+2.36%↑

MDT

86.5

-0.05%↓

113.77

-1.1%↓

VEEV

171.16

-1.2%↓

HQY

81.09

-3.2%↓

PHR.US

9.11

+2.36%↑

MDT

86.5

-0.05%↓

113.77

-1.1%↓

VEEV

171.16

-1.2%↓

HQY

81.09

-3.2%↓

PHR.US

9.11

+2.36%↑

Home・Akcijų sąrašas・CEL-SCI Corp

CEL-SCI Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

4.51 17.14

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.69

Max

4.51

Pagrindiniai rodikliai
By Trading Economics
Pajamos	631K -5.5M
Pelnas, tenkantis vienai akcijai	-0.68
EBITDA	607K -4.4M

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-14

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-15M 26M
Ankstesnė atidarymo kaina	-12.63
Ankstesnė uždarymo kaina	4.51

Naujienos nuotaikos

By Acuity

65%

35%

320 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

N/A / 0.2494 Palaikymas ir pasipriešinimas

CEL-SCI Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-06 23:17; UTC

Uždarbis

Samsung Forecasts Record First-Quarter Operating Profit

2026-04-06 23:00; UTC

Karštos akcijos

Stocks to Watch: Health Insurers, Mawson, Owlet

2026-04-06 22:13; UTC

Pagrindinės rinkos jėgos

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

2026-04-06 21:46; UTC

Įsigijimai, susijungimai, perėmimai

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

2026-04-06 17:09; UTC

Pagrindinės rinkos jėgos

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

2026-04-06 16:56; UTC

Svarbiausios naujienos

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

2026-04-06 14:47; UTC

Pagrindinės rinkos jėgos

Stereotaxis Shares Rise on FDA Clearance for Synchrony

2026-04-07 00:00; UTC

Svarbiausios naujienos

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

2026-04-06 23:58; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

2026-04-06 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

2026-04-06 23:36; UTC

Rinkos pokalbiai

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

2026-04-06 23:15; UTC

Rinkos pokalbiai

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

2026-04-06 22:52; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-06 22:52; UTC

Rinkos pokalbiai

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

2026-04-06 22:14; UTC

Rinkos pokalbiai

Correction to Live Cattle Futures Article

2026-04-06 20:56; UTC

Rinkos pokalbiai

Mexican Private Consumption Fell in January -- Market Talk

2026-04-06 20:50; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2026-04-06 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-06 19:58; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-06 19:58; UTC

Rinkos pokalbiai

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

2026-04-06 19:11; UTC

Rinkos pokalbiai

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

2026-04-06 19:06; UTC

Rinkos pokalbiai

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

2026-04-06 19:03; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-04-06 19:03; UTC

Rinkos pokalbiai

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

2026-04-06 18:36; UTC

Įsigijimai, susijungimai, perėmimai

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

2026-04-06 17:59; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

2026-04-06 17:13; UTC

Įsigijimai, susijungimai, perėmimai

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

2026-04-06 16:33; UTC

Rinkos pokalbiai

Oil Futures Steady as Market Awaits Trump -- Market Talk

2026-04-06 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-04-06 14:59; UTC

Uždarbis

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Akcijų palyginimas

Kainos pokytis

CEL-SCI Corp Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių CEL-SCI Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

N/A / 0.2494Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

There is one bullish event.

There is one bearish event.

Rinkos nuotaikos

By Acuity

320 / 349 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Kitos sektoriaus akcijos

MDT

Medtronic PLC

86.5

↓-0.05%

Agilent Technologies Inc

113.77

↓-1.1%

VEEV

Veeva Systems Inc

171.16

↓-1.2%

HQY

HealthEquity Inc

81.09

↓-3.2%

PHR.US

Phreesia Inc

9.11

↑ +2.36%

CEL-SCI Corp

Apžvalga

Akcijų kainos pasikeitimas

Pagrindiniai rodikliai

Dividendai

Rinkos statistika

Naujienos nuotaikos

Techninis įvertinimas

CEL-SCI Corp Grafikas

Susijusios naujienos

Akcijų palyginimas

CEL-SCI Corp Prognozė

Bendras įvertinimas

Techninis įvertinimas

Rinkos nuotaikos

Finansinės naujienos

Kitos sektoriaus akcijos